We are live on ! Find out more
RSC

Red Spruce Capital Portfolio holdings

AUM $287M
1-Year Est. Return 38.81%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+38.81%
3 Year Est. Return
+93.31%
5 Year Est. Return
+110.88%
10 Year Est. Return
AUM
$245M
AUM Growth
+$14.5M
Cap. Flow
-$41.3K
Cap. Flow %
-0.02%
Top 10 Hldgs %
36.59%
Holding
93
New
3
Increased
38
Reduced
39
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 22.43%
2 Industrials 13.49%
3 Healthcare 12.64%
4 Communication Services 11.79%
5 Financials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STWD icon
76
Starwood Property Trust
STWD
$5.92B
$648K 0.26%
33,475
+3
+0% +$60
CORZ icon
77
Core Scientific
CORZ
$6.66B
$596K 0.24%
33,221
TYL icon
78
Tyler Technologies
TYL
$12.7B
$562K 0.23%
1,075
SYK icon
79
Stryker
SYK
$125B
$456K 0.19%
1,234
+61
+5% +$23.6K
BX icon
80
Blackstone
BX
$102B
$407K 0.17%
2,384
+13
+0.5% +$2.23K
PH icon
81
Parker-Hannifin
PH
$123B
$406K 0.17%
536
CTAS icon
82
Cintas
CTAS
$81.9B
$401K 0.16%
1,954
+494
+34% +$106K
AAPL icon
83
Apple
AAPL
$4.54T
$353K 0.14%
1,385
+62
+5% +$14K
COHR icon
84
Coherent
COHR
$51.4B
$335K 0.14%
3,113
CW icon
85
Curtiss-Wright
CW
$26.7B
$328K 0.13%
+605
New +$298K
AJG icon
86
Arthur J. Gallagher & Co
AJG
$64.1B
$325K 0.13%
1,050
VTI icon
87
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$259K 0.11%
789
+5
+0.6% +$1.58K
LQD icon
88
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$246K 0.1%
2,207
TMO icon
89
Thermo Fisher Scientific
TMO
$213B
$244K 0.1%
504
SCHB icon
90
Schwab US Broad Market ETF
SCHB
$43.2B
$244K 0.1%
9,507
ISRG icon
91
Intuitive Surgical
ISRG
$127B
$229K 0.09%
+511
New +$245K
VUG icon
92
Vanguard Morningstar Growth ETF
VUG
$220B
$205K 0.08%
+2,562
New +$196K
ANSS
93
DELISTED
Ansys
ANSS
-1,653
Closed -$581K

Similar funds

Red Spruce Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Red Spruce Capital held 93 positions worth $245M, up 6.3% from $231M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4.3%. Red Spruce Capital opened 3 new positions and exited 1, leaving the 93-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Red Spruce Capital's largest Q3 2025 buy was Curtiss-Wright: 605 shares worth $328K.
  • Red Spruce Capital added most to Eli Lilly in Q3 2025, an estimated $1.54M increase.
  • Red Spruce Capital's biggest Q3 2025 reduction was Merck, cutting an estimated $1.35M.
  • Red Spruce Capital fully exited Ansys in Q3 2025, selling an estimated $581K.
  • Red Spruce Capital's ten largest holdings make up 37% of its $245M portfolio in Q3 2025.
  • Red Spruce Capital opened 3 new positions and closed 1 in Q3 2025.
  • Red Spruce Capital's portfolio value rose 6.3% quarter-over-quarter to $245M.

Based on Red Spruce Capital's 13F filing for Q3 2025, filed 6 Oct 2025.